Phase 1 dose escalation trial of the novel vascular disrupting agent NPI-2358

Monica Mita,Matthew A. Spear,Lorrin Yee,K. Papadopoulos,Elisabeth Heath,Ofelia Romero,G. K. Lloyd,G. Cropp,Alain Mita,Patricia LoRusso

Phase 1 dose escalation trial of the novel vascular disrupting agent NPI-2358

2008

Monica Mita
Matthew A. Spear
Lorrin Yee
K. Papadopoulos
Elisabeth Heath
Ofelia Romero
G. K. Lloyd
G. Cropp
Alain Mita
Patricia LoRusso

LB-202 Abstract LB-202 was submitted as a Late-Breaking Abstract and is embargoed until the time of presentation. The complete abstract will be posted to this site at or after the following date and time: 4/14/2008 2:30 PM.

Keywords:

Immunology
Pharmacology
Medicine
dose escalation
Oncology
Internal medicine

Correction
Cite
Save
Machine Reading By IdeaReader

References

Citations